Entasis Therapeutics
Entasis Therapeutics, a subsidiary of Innoviva, Inc, is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
7
51 to 200 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 7 verified contacts at Entasis Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- JC
Jurkowski Claire
Consultant · Science
EmailPhone - JP
John P. Mueller
Chief Development Officer · General Business & Management
EmailPhone - LO
Linda Olsen
Gmp Qa Primary Analytical Reviewer · Other
EmailPhone - MC
Mary Crosby Stack
VP of Finance · Other
EmailPhone - JO
John Odonnell
Director of Dmpk · Research & Development
EmailPhone - MG
Maryellen Garrett
Sr Director, Corporate Controller · Finance & Accounting
EmailPhone
Showing 6 of 7 verified contacts
Top roles at Entasis Therapeutics
6 distinct titles indexed · top 6 shown.
- 2consultant
- 1chief development officer
- 1director of dmpk
- 1gmp qa primary analytical reviewer
- 1sr director, corporate controller
- 1vp of finance
Sign up to unlock all 7 contacts at Entasis Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Entasis Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.